Gold nanoparticle-enhanced photodynamic therapy: Effects of surface charge and mitochondrial targeting

Therapeutic Delivery

Volumn 6, Issue 3, 2015, Pages 307-321

  Yang, Yamin ^a   Gao, Ning ^a,b   Hu, Yue ^a   Jia, Chao ^a   Chou, Tsengming ^a   Du, Henry ^a   Wang, Hongjun ^a  

^a Stevens Institute of Technology   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; GOLD NANOPARTICLE; OXYGEN; PHOSPHONIUM DERIVATIVE; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; GOLD; METAL NANOPARTICLE;

ABSORPTION SPECTROSCOPY; ARTICLE; BREAST CANCER CELL LINE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL PHAGOCYTOSIS; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG UPTAKE; HUMAN; HUMAN CELL; INCUBATION TIME; LASER; LIGHT EXPOSURE; LIGHT SCATTERING; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL TARGETING SIGNAL; OXIMETRY; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PLASMON RESONANCE; SURFACE PROPERTY; THERAPY EFFECT; METABOLISM; MITOCHONDRION; PHOTOCHEMOTHERAPY; PROCEDURES; TUMOR CELL LINE;

CELL LINE, TUMOR; GOLD; HUMANS; METAL NANOPARTICLES; MITOCHONDRIA; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES;

EID: 84927669518     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.14.115     Document Type: Article

References (60)

1. Sibata CH, Colussi VC, Oleinick NL et al. Photodynamic therapy: a new concept in medical treatment. Braz. J. Med. Biol. Res. 33(8), 869-880 (2000).
2. Yang Y, Wang H. Perspectives of nanotechnology in minimally invasive therapy of breast cancer. J. Healthc. Eng. 4(1), 67-86 (2013).
3. Yang Y, Wang H. Applications of nanomaterials for cancer treatment: recent patents review. Recent Pat. Nanomed. 3(2), 75-82 (2013).
4. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J. Natl Cancer Inst. 90(12), 889-905 (1998).
5. Shackley DC, Whitehurst C, Moore J V et al. Photodynamic therapy. J. R. Soc. Med. 92, 562-565 (1999).
6. Huang Z, Xu H, Meyers AD et al. Photodynamic therapy for treatment of solid tumors-potential and technical challenges. Technol. Cancer Res. Treat. 7(4), 309-320 (2008).
7. Lukšienė Ž. Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment. Medicina (Kaunas) 39(12), 1137-1150 (2003).
8. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat. Rev. Cancer 3(5), 380-387 (2003).
9. Master AM, Qi Y, Oleinick NL et al. EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies. Nanomedicine 8(5), 655-664 (2012).
10. Khaing Oo MK, Yang X, Du H et al. 5-aminolevulinic acidconjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine 3(6), 777-786 (2008).
11. Oo MKK, Yang Y, Hu Y et al. Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX. ACS Nano 6(3), 1939-1947 (2012).
12. Yang Y, Hu Y, Du H et al. Intracellular induced gold nanoaggregates by electrostatic interaction and their applications in photodynamic therapy. Chem. Commun. (Camb). 50(55), 7287-7290 (2014).
13. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4), 662-668 (2006).
14. Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res. 12(7), 2313-2333 (2010).
15. Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1-16 (2012).
16. Cho EC, Au L, Zhang Q et al. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small 6(4), 517-522 (2011).
17. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 6(1), 12-21 (2010).
18. Abercrombie M, Ambrose EJ, Abercrombie A et al. The surface properties of cancer cells: a review. Cancer Res. 22, 525-548 (1962).
19. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria as targets for chemotherapy. Apoptosis 14(4), 624-640 (2009).
20. Zhao J, Zhang J, Yu M et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32(40), 4814-4824 (2012).
21. Wallace DC. Mitochondria and cancer. Nat. Rev. Cancer. 12(10), 685-698 (2012).
22. Lei W, Xie J, Hou Y et al. Mitochondria-targeting properties and photodynamic activities of porphyrin derivatives bearing cationic pendant. J. Photochem. Photobiol. B. 98(2), 167-171 (2010).
23. Wachowska M, Muchowicz A, Firczuk M et al. Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer. Molecules 16(5), 4140-4164 (2011).
24. Manczak M, Mao P, Calkins MJ et al. Mitochondria-targeted antioxidants protect against Abeta toxicity in Alzheimer's disease neurons. J. Alzheimers Dis. 20(Suppl. 2) S609-S631 (2010).
25. Szeto HH, Schiller PW. Novel therapies targeting inner mitochondrial membrane-from discovery to clinical development. Pharm. Res. 28(11), 2669-2679 (2011).
26. Ragg R, Natalio F, Tahir MN et al. Molybdenum trioxide nanoparticles with intrinsic sulfite oxidase activity. ACS Nano 8(5), 5182-5189 (2014).
27. Wang X-H, Peng H-S, Yang L et al. Poly-L-lysine assisted synthesis of core-shell nanoparticles and conjugation with triphenylphosphonium to target mitochondria. J. Mater. Chem. B. 1, 5143-5152 (2013).
28. Marrache S, Dhar S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc. Natl Acad. Sci. USA 109(40), 16288-16293 (2012).
29. Ju-Nam Y, Bricklebank N, Allen DW et al. Phosphonioalkylthiosulfate zwitterions-new masked thiol ligands for the formation of cationic functionalised gold nanoparticles. Org. Biomol. Chem. 4(23), 4345-4351 (2006).
30. Abdelhalim MAK, Mady MM. Physical properties of different gold nanoparticles: ultraviolet-visible and fluorescence measurements. J. Nanomed. Nanotechnol. 3(3), 1-5 (2012).
31. Yamamoto J, Yamamoto S, Hirano T et al. Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma. Clin. Cancer Res. 12(23), 7132-7139 (2006).
32. Marshall KC. In vivo electrophysiological maturation of neurons derived from a multipotent precursor (embryonal carcinoma) cell line. Brain Res. Dev. Brain Res. 84(1), 130-141 (1995).
33. Leroueil PR, Hong S, Mecke A et al. Nanoparticle interaction with biological membranes. Acc. Chem. Res. 40(5), 335-342 (2008).
34. Cho K, Wang X, Nie S et al. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14(5), 1310-1316 (2008).
35. Yue Z, Wei W, Lv P et al. Surface charge affects cellular uptake and intracellular trafficking of. Biomacromolecules 12(7), 2440-2446 (2011).
36. Arvizo RR, Miranda OR, Thompson M et al. Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett. 10(7), 2543-2548 (2010).
37. Yu J, Baek M, Chung HE et al. Effects of physicochemical properties of zinc oxide nanoparticles on cellular uptake. J. Phys. Conf. Ser. 304, 012007 (2011).
38. Rasmussen JW, Martinez E, Louka P et al. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin. Drug Deliv. 7(9), 1063-1077 (2011).
39. Chen L, Mccrate JM, Lee JC-M et al. The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology 22(10), 105708 (2011).
40. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188(6), 759-768 (2010).
41. Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 11(4), 671-681 (2009).
42. Kim CH, Chung C-W, Choi KH et al. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int. J. Nanomedicine. 6, 1357-1363 (2011).
43. Pudroma X, Moan J, Ma L-W et al. A comparison of 5-aminolaevulinic acid- and its heptyl ester: Dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma cells and in athymic nude mice healthy skin. Exp. Dermatol. 18(11), 985-987 (2009).
44. Millon SR, Ostrander JH, Yazdanfar S et al. Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes. J. Biomed. Opt. 15(1), 018002 (2010).
45. Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 1, 1-21 (2002).
46. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150(5 Suppl.), S146-S156 (1998).
47. Peng Q, Warloe T, Moan J et al. 5-Aminolevulinic acidbased photodynamic therapy. Clinical research and future challenges. Cancer 79(12), 2282-2308 (1997).
48. Lu W, Ogasawara M, Huang P. Models of reactive oxygen species in cancer. Drug Discov. Today. Dis. Models 4(2), 67-73 (2007).
49. Nathan AT, Singer M. The oxygen trail: tissue oxygenation. Br. Med. Bull. 55(1), 96-108 (1999).
50. Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv. Drug Deliv. Rev. 61(4), 290-302 (2009).
51. Modica-Napolitano JS, Singh K. Mitochondria as targets for detection and treatment of cancer. Expert Rev. Mol. Med. 4(9), 1-19 (2004).
52. Lévy R, Shaheen U, Cesbron Y et al. Gold nanoparticles delivery in mammalian live cells: a critical review. Nano Rev. 1, 4489 (2010).
53. Guo S, Huang L. Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy. J. Nanomater. 2011, 1-12 (2011).
54. Akita H, Enoto K, Masuda T et al. Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus. Mol. Ther. 18(5), 955-964 (2010).
55. Wang L, Liu Y, Li W et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett. 11(2), 772-780 (2011).
56. Michelakis ED. Mitochondrial medicine: a new era in medicine opens new windows and brings new challenges. Circulation 117(19), 2431-2434 (2008).
57. Grandinetti G, Ingle NP, Reineke TM. Interaction of poly(ethylenimine)-DNA polyplexes with mitochondria; implications for a mechanism of cytotoxicity. Mol. Pharm. 8(5), 1709-1719 (2012).
58. Moghimi SM, Symonds P, Murray JC et al. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 11(6), 990-995 (2005).
59. Murphy MP. Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol. 15(8), 326-330 (1997).
60. Ketterer B, Neumcke B, Läuger P. Transport mechanism of hydrophobic ions through lipid bilayer membranes. J. Membr. Biol. 5(3), 225-245 (1971).